Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Humoral response and breakthrough infections with SARS-CoV-2 B.1.617.2 variant in vaccinated maintenance hemodialysis patients
Ori Wand, Naomi Nacasch, Ayman Fadeela, et al.
Journal of Nephrology (2022) Vol. 35, Iss. 5, pp. 1479-1487
Open Access | Times Cited: 19

Showing 19 citing articles:

Co-infection with SARS-CoV-2 Omicron and Delta variants revealed by genomic surveillance
Rebecca J. Rockett, Jenny Draper, Mailie Gall, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 84
Immune response after two doses of the BNT162b2 COVID-19 vaccine and risk of SARS-CoV-2 breakthrough infection in Tyrol, Austria: an open-label, observational phase 4 trial
Lisa Seekircher, Zoltán Bánki, Janine Kimpel, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 8, pp. e612-e621
Open Access | Times Cited: 18
Prognostic value of anti-SARS-CoV-2 antibodies: a systematic review
Sylvia Mink, Patrick Reimann, Peter Fraunberger
Clinical Chemistry and Laboratory Medicine (CCLM) (2024) Vol. 62, Iss. 6, pp. 1029-1043
Open Access | Times Cited: 7
Improved SARS-CoV-2 Neutralization of Delta and Omicron BA.1 Variants of Concern after Fourth Vaccination in Hemodialysis Patients
Cho‐Chin Cheng, Louise Platen, Catharina Christa, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1328-1328
Open Access | Times Cited: 17
Clinical manifestations of COVID-19 infection in dialysis patients and protective effect of COVID-19 vaccine
Xuehan Zhang, Qingfeng Chen, Gaosi Xu
Inflammation Research (2023) Vol. 72, Iss. 5, pp. 989-1000
Open Access | Times Cited: 9
Humoral Response after Three Doses of mRNA-1273 or BNT162b2 SARS-CoV-2 Vaccines in Hemodialysis Patients
José Jesús Broseta, Diana Rodríguez‐Espinosa, Elena Cuadrado, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 522-522
Open Access | Times Cited: 14
Active vitamin D analog and SARS‐CoV‐2 IgG after BNT162b2 vaccination in patients with hemodialysis
Akio Nakashima, Izumi Yamamoto, Arisa Kobayashi, et al.
Therapeutic Apheresis and Dialysis (2024) Vol. 28, Iss. 4, pp. 599-607
Open Access | Times Cited: 1
What has vaccination against COVID-19 in CKD patients taught us?
Mattia Rossi, Giuseppina Pessolano, Giovanni Gambaro
Journal of Nephrology (2023) Vol. 36, Iss. 5, pp. 1257-1266
Open Access | Times Cited: 4
Clinical efficacy of the fourth dose of the BNT162b2 vaccine in maintenance dialysis patients
Keren Cohen‐Hagai, Tzipi Hornik‐Lurie, Sydney Benchetrit, et al.
Journal of Nephrology (2023) Vol. 36, Iss. 7, pp. 1957-1964
Closed Access | Times Cited: 4
Comparison of Humoral Response between Third and Fourth Doses of COVID-19 Vaccine in Hemodialysis Patients
Y.D. Joo, Dae Kyu Kim, Yun Gi Jeon, et al.
Vaccines (2023) Vol. 11, Iss. 10, pp. 1584-1584
Open Access | Times Cited: 4
One-year dynamics of antibody titers after three doses of SARS-CoV-2 BNT162b2 vaccine
Ori Wand, Anna Breslavsky, Amir Bar‐Shai, et al.
Vaccine (2022) Vol. 41, Iss. 4, pp. 871-874
Open Access | Times Cited: 5
Immune response to 2-dose BNT162b2 vaccination and risk of SARS-CoV-2 breakthrough infection: The Shieldvacc-2 study
Lisa Seekircher, Zoltán Bánki, Janine Kimpel, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Durable Anti-SARS-CoV-2 Antibody Response after mRNA-1273 Booster in Peritoneal Dialysis Patients during the Omicron Wave
Georg F. Beilhack, Rossella Monteforte, Florian Frommlet, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1121-1121
Open Access | Times Cited: 2
Humoral Response to Hepatitis B and COVID-19 Vaccine among Maintenance Hemodialysis Patients
Naomi Nacasch, Keren Cohen‐Hagai, Nurit Tayar, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1670-1670
Open Access | Times Cited: 3
SARS-CoV-2 Omicron Infections among Vaccinated Maintenance Hemodialysis Patients: Outcomes and Comparison to Delta Variant
Ori Wand, Idan Drori, Yael Einbinder, et al.
˜The œNephron journals/Nephron journals (2024) Vol. 148, Iss. 9, pp. 601-608
Open Access
Kinetics of the humoral response 1-year following vaccination with BNT162b2 SARS-CoV-2 vaccine among maintenance hemodialysis patients
Ori Wand, Yael Einbinder, Naomi Nacasch, et al.
Journal of Nephrology (2022) Vol. 36, Iss. 1, pp. 213-216
Open Access | Times Cited: 2
Improved SARS-CoV-2 neutralization of Delta and Omicron variants of concern after fourth vaccination in hemodialysis patients
Cho‐Chin Cheng, Louise Platen, Catharina Christa, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Assessment of Predictors for SARS-CoV-2 Antibodies Decline Rate in Health Care Workers after BNT162b2 Vaccination—Results from a Serological Survey
Nadav Zacks, Amir Bar‐Shai, Hezi Levi, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1443-1443
Open Access | Times Cited: 1
Active Vitamin D analog and SARS-CoV-2 IgG after BNT162b2 vaccination in patients with hemodialysis
Akio Nakashima, Izumi Yamamoto, Arisa Kobayashi, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top